AcelRx Pharma (ACRX) Files $25M Common Shelf
Tweet Send to a FriendGet Alerts ACRX Hot Sheet
Up)
Trade ACRX Now!
AcelRx Pharmaceuticals (NASDAQ: ACRX) filed a registration with the U.S. SEC to sell, from time to time, up to $25 million of its common stock.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Canaccord Boosts PT on AcelRx (ACRX) to $11; On Track for Sufentanil NDA Submission by Q313
- Apricus Biosciences (APRI) Sinks on Stock Offering
- Baltic Trading (BALT) to Sell 5.58M Common at $3.60/Share
Create E-mail Alert Related Categories
Equity Offerings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
